Kitasato University’s special honorary professor Satoshi Omura (right) explaining the antiparasitic drug “ivermectin” = 6th, Minato-ku, Tokyo
COVID-19: Kitasato Univ., To ivermectin clinical trial: antiparasitic drug, new corona
Kitasato University:
On May 6, announced that we would aim to approve ivermectin as a therapeutic drug for new-type coronavirus infections and announced that he would conduct a clinical trial.
Special honorary professor Satoshi Omura of the Nobel Prize in Physiology or Physiology is developing the antiparasitic drug “ivermectin”.
Yasutoshi Nishimura: Minister for Economic Recovery
Minister Nishimura visited Kitasato University.
Mr. Yasutoshi Nishimura, Minister for Economic Recovery, explained the test situation of the therapeutic drug by the person in charge.
Kitasato Univ .: Ivermectin administration status
It is administered to patients who have given their consent, and the effects of improving symptoms and the presence of side effects are confirmed.
Administer to desired patients at Kitasato University Hospital and consider observational studies.
The start date and scale of the clinical trial have not been determined.
Ivermectin:
A silver bullet for tropical infectious diseases caused by parasites spreading in Africa and Asia.
Studies in foreign countries such as the United States and Australia have reported the effect of suppressing the growth of new coronavirus.
kyodo communication